1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA DKK1 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA CACHD1 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA PHF3 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA NKX2-4 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA SDK1 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA BCL2 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA RAB9B CTRPv2 pan-cancer AAC 0.11 0.003
mRNA AC009336.19 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA GSK3B CTRPv2 pan-cancer AAC 0.11 0.003
mRNA TTLL7 CTRPv2 pan-cancer AAC 0.11 0.003
Download CSV